AIMC Topic: Biomarkers, Tumor

Clear Filters Showing 1341 to 1350 of 1403 articles

An artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.

Briefings in bioinformatics
Although the prognosis of lower-grade glioma (LGG) patients is better than others, outcomes are highly heterogeneous. Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status can identify patient subsets with different prognosis. However,...

Prediction of tumor purity from gene expression data using machine learning.

Briefings in bioinformatics
MOTIVATION: Bulk tumor samples used for high-throughput molecular profiling are often an admixture of cancer cells and non-cancerous cells, which include immune and stromal cells. The mixed composition can confound the analysis and affect the biologi...

A comprehensive overview and critical evaluation of gene regulatory network inference technologies.

Briefings in bioinformatics
Gene regulatory network (GRN) is the important mechanism of maintaining life process, controlling biochemical reaction and regulating compound level, which plays an important role in various organisms and systems. Reconstructing GRN can help us to un...

GAERF: predicting lncRNA-disease associations by graph auto-encoder and random forest.

Briefings in bioinformatics
Predicting disease-related long non-coding RNAs (lncRNAs) is beneficial to finding of new biomarkers for prevention, diagnosis and treatment of complex human diseases. In this paper, we proposed a machine learning techniques-based classification appr...

Artificial intelligence technologies empowering identification of novel diagnostic molecular markers in gastric cancer.

Indian journal of pathology & microbiology
In recent clinical practice the molecular diagnostics have been significantly empowered and upgraded by the use of Artificial Intelligence and its assisted technologies. The use of Machine leaning and Deep Learning Neural network architectures have b...

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.

Journal for immunotherapy of cancer
BACKGROUND: Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) experience a durable clinical benefit (DCB). According to NCCN guidelines, Programmed death-ligand 1 (PD-L1) e...

Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.

The Lancet. Digital health
BACKGROUND: The tumour stroma microenvironment plays an important part in disease progression and its composition can influence treatment response and outcomes. Histological evaluation of tumour stroma is limited by access to tissue, spatial heteroge...

Perspectives in pathomics in head and neck cancer.

Current opinion in oncology
PURPOSE OF REVIEW: Pathology is the cornerstone of cancer care. Pathomics, which represents the use of artificial intelligence in digital pathology, is an emerging and promising field that will revolutionize medical and surgical pathology in the comi...

Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.

The Journal of clinical investigation
BACKGROUNDPatients with p16+ oropharyngeal squamous cell carcinoma (OPSCC) are potentially cured with definitive treatment. However, there are currently no reliable biomarkers of treatment failure for p16+ OPSCC. Pathologist-based visual assessment o...

Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.

Pancreas
Despite considerable research efforts, pancreatic cancer is associated with a dire prognosis and a 5-year survival rate of only 10%. Early symptoms of the disease are mostly nonspecific. The premise of improved survival through early detection is tha...